Ebos Group Ltd

EBO: XNZE (NZL)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
LOCK|.QLOCK|>w@M%LOCK|mN<FG$<<

Ebos Group Earnings: Competition in Pharmacy Unlikely to Abate

Ebos' revenue increased 10% to AUD 13.5 billion in fiscal 2026 year-on-year. Yet, margins decreased and underlying EBITDA rose only 5%, in line with guidance. Its recent capital expenditure spree is complete, with focus shifting to driving efficiencies from new infrastructure. Shares rallied 8%.

Sponsor Center